Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Feijtel

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Topics in Medicinal Chemistry|February 27, 2020
Peptide Receptor Radionuclide Therapy: Looking Back, Looking ForwardDanny Feijtel, Marion de Jong, Julie Nonnekens
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2021
Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo SurvivalGiulia Tamborino, Julie Nonnekens, Marijke De Saint-Hubert, et al.
Theranostics|January 4, 2021
Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy responseDanny Feijtel, Gabriela N Doeswijk, Nicole S Verkaik, et al.
Cell Reports|August 30, 2018
Paneth Cells Respond to Inflammation and Contribute to Tissue Regeneration by Acquiring Stem-like Features through SCF/c-Kit SignalingMark Schmitt, Matthias Schewe, Andrea Sacchetti, et al.
Cancers|February 11, 2023
In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using OlaparibDanny Feijtel, Thom G A Reuvers, Christine van Tuyll-van Serooskerken, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Topics in Medicinal Chemistry|February 27, 2020
Peptide Receptor Radionuclide Therapy: Looking Back, Looking ForwardDanny Feijtel, Marion de Jong, Julie Nonnekens
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2021
Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo SurvivalGiulia Tamborino, Julie Nonnekens, Marijke De Saint-Hubert, et al.
Theranostics|January 4, 2021
Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy responseDanny Feijtel, Gabriela N Doeswijk, Nicole S Verkaik, et al.
Cell Reports|August 30, 2018
Paneth Cells Respond to Inflammation and Contribute to Tissue Regeneration by Acquiring Stem-like Features through SCF/c-Kit SignalingMark Schmitt, Matthias Schewe, Andrea Sacchetti, et al.
Cancers|February 11, 2023
In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using OlaparibDanny Feijtel, Thom G A Reuvers, Christine van Tuyll-van Serooskerken, et al.
Pageof 1